Weight gain secondary to the use of Janus kinase inhibitors

被引：1

作者：

Ch'en, Peter Yi ^{[1
]}

Ng, Justin ^{[2
]}

Song, Eingun James ^{[3
]}

机构：

[1] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA

[2] Coll Osteopath Med Pacific Northwest, Lebanon, OR USA

[3] Frontier Dermatol, Mill Creek, WA USA

来源：

ARCHIVES OF DERMATOLOGICAL RESEARCH | 2023年 / 315卷 / 10期

关键词：

General dermatology; Medical dermatology; Oncology; Drug response; Clinical research; Surgery; RUXOLITINIB;

D O I：

10.1007/s00403-023-02710-6

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：2773 / 2774

页数：2

共 13 条

[1] Experience with ruxolitinib in the treatment of polycythaemia vera [J].

Alimam, Samah ;

Harrison, Claire .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (04) :139-151

[2]

[Anonymous], 2022, UNP INT CO DAT

[3]

[Anonymous], 2022, STUDY BARICITINIB LY

[4] Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism [J].

Chikugo, Momoko ;

Sebe, Mayu ;

Tsutsumi, Rie ;

Iuchi, Marina ;

Kishi, Jun ;

Kuroda, Masashi ;

Harada, Nagakatsu ;

Nishioka, Yasuhiko ;

Sakaue, Hiroshi .

JOURNAL OF MEDICAL INVESTIGATION, 2018, 65 (3-4) :166-170

[5] Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera [J].

Coltoff, Alexander ;

Mesa, Ruben ;

Gotlib, Jason ;

Shulman, Jessica ;

Rampal, Raajit K. ;

Siwoski, Olivia ;

Yacoub, Abdulraheem ;

Moliterno, Alison ;

Yang, Anna ;

Braunstein, Evan ;

Gerds, Aaron T. ;

Hobbs, Gabriela S. ;

Winton, Elliott F. ;

Goel, Swati ;

Wadleigh, Martha ;

Tremblay, Douglas ;

Moshier, Erin ;

Mascarenhas, John .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10) :697-+

[6] JAK inhibitors in dermatology: The promise of a new drug class [J].

Damsky, William ;

King, Brett A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) :736-744

[7] Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure [J].

Liu, Lucy Y. ;

Strassner, James P. ;

Refat, Maggi A. ;

Harris, John E. ;

King, Brett A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) :675-+

[8] Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3 [J].

Molle, Nicole ;

Krichevsky, Spencer ;

Kermani, Pouneh ;

Silver, Richard T. ;

Ritchie, Ellen ;

Scandura, Joseph M. .

BLOOD, 2020, 135 (13) :1062-1066

[9] Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib [J].

Novikova, Diana S. ;

Udachkina, Helen V. ;

Markelova, Eugenia I. ;

Kirillova, Irina G. ;

Misiyuk, Anna S. ;

Demidova, Natalia V. ;

Popkova, Tatiana V. .

RHEUMATOLOGY INTERNATIONAL, 2019, 39 (07) :1181-1189

[10]

RINVOQ, 2022, HIGHL PRESCR INF

← 1 2 →